The Food and Drug Administration (FDA) has approved DefenCath ® (taurolidine and heparin) catheter lock solution to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult ...
We conducted a single-center, open-label trial in Germany that involved patients with symptomatic atrial fibrillation and end-stage heart failure who were referred for heart transplantation evaluation ...
MÖLNDAL, Sweden, April 30, 2026 /PRNewswire/ -- Today, Wellspect HealthCare launched the Surity™ Male External Catheter, a non-invasive solution for men living with urinary incontinence. This builds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results